Skip to main content.

Myeloma and Amyloidosis Disorder Program

The Myeloma and Amyloidosis Disorder Program team is committed to developing and expanding research efforts through collaboration in an effort to find treatments for myeloma.

Our physician investigators engage in innovative research to develop and implement novel and effective treatments for myeloma. Our team includes clinical and research faculty, physician faculty who are experts in bone marrow transplants and collaborators in research, teaching and patient care. Visit KU Cancer Center for more information about myeloma diagnosis and treatment.

About Our Team

Clinical and Research Faculty

Sid Ganguly, M.D.
Professor of Medicine
Deputy Director, Hematologic Malignancies and Cellular Therapeutics

Al-Ola Abdallah, M.D.
Assistant Professor of Medicine

Leyla Shune, M.D.
Assistant Professor of Medicine

Physician Faculty

Sunil Abhyankar, M.D.
Professor of Medicine
Medical Director, Pheresis and Cell Processing

Tara Lin, M.D.
Associate Professor of Medicine

Joseph McGuirk, D.O.
Schutte-Speas Professor of Hematology-Oncology
Division Director, Division of Hematologic Malignancies and Cellular Therapeutics
Medical Director, Blood and Marrow Transplant Program

Anurag Singh, M.D.
Associate Professor of Medicine

Collaborating Research Scientist

Andy Godwin, Ph.D.
Chancellors Distinguished Chair in Biomedical Sciences and Endowed Professor
Professor and Director of Molecular Oncology, Pathology & Laboratory Medicine

Associated Faculty

  • Ahmad Tuffaha, M.D.- Nephrology
  • Dawood Sayed, M.D.- Anesthesiology
  • Charles Porter, M.D.- Cardiovascular Medicine
  • Meagan Dwyer, Ph.D.- Oncology Psychology
  • Jessica Hamilton, Ph.D.- Oncology Psychology
  • Elizabeth Muenks,Ph.D.- Oncology Psychology
  • Karin Porter-Williamson, M.D.- Palliative Care
  • Christian Sinclair, M.D.- Palliative Care
  • Megan Clark, M.D.- Oncology Rehabilitation
  • Mazen M Dimachkie, M.D.- Neurology
  • Mamatha Pasnoor, M.D.- Neurology

Clinical Trials

Explore all of our clinical studies underway at The University of Kansas Cancer Center, or reach out for more information.

Contact our Clinical Trial Nurse Navigator:
Phone: 913-945-7552

Featured Clinical Trials:

  • Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients
  • Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant (ASCENT)
  • An Exploratory Trial to Estimate the Proportion of Patients With Tumor Cell Contaminated, Flow Positive Leukapheresis Products Collected With and Without Bortezomib as In-vivo Purging Prior to Autologous Stem Cell Harvest for Multiple Myeloma

All Myeloma Clinical Trials:

Support Programs

Visit KU Cancer Center for information about support groups and other resources for patients and families. Visit Gilda's Club (support for all cancers and stages) or Cancer Action (for programs and services of persons with cancer, their family and friends).

Internal Medicine

University of Kansas Medical Center
Internal Medicine
Medical Oncology Division
2330 Shawnee Mission Pkwy
Westwood, KS 66205
Administrative Office: 913-588-6030
Fellowship: 913-588-0348